Different KIT mutations affect the apoptotic signal transduction caused by imatinib in GISTs, as observed by Noma and colleagues in the GIST-T1 and the GIST882 lines, carrying activating mutant KIT. This evidence concerns the gene KIT and gastrointestinal stromal tumor.